PCSK9 Inhibitors in Heart Transplant Patients: Safety, Efficacy, and Angiographic Correlates
Yasser Sammour, Christopher DeZorzi, Bethany A. Austin, A. Michael Borkon, M.P. Everley, Timothy J. Fendler, Taiyeb Khumri, S.L. Lawhorn, Michael E. Nassif, Deepthi Vodnala, Anthony Magalski, Andrew Kao, Brett W. Sperry
Topics & Concepts
MedicinePCSK9Interquartile rangeEvolocumabIntravascular ultrasoundInternal medicineHeart transplantationCardiologyAlirocumabHyperlipidemiaCholesterolGastroenterologyUrologyApolipoprotein BTransplantationLipoproteinEndocrinologyDiabetes mellitusLDL receptorApolipoprotein A1Transplantation: Methods and OutcomesLipoproteins and Cardiovascular HealthViral Infections and Immunology Research